Therataxis's research and development is focused on planning, executing, and monitoring the targeted delivery of therapies into the brain. Our core technologies center on the modeling and simulation of brain response to therapy. The current focus is to predict the distribution of agents delivered directly into tissue and to develop simulation-based delivery-device designs. Our first efforts address brain parenchyma, but the methods can also apply to tissues such as liver, prostate, and breast.